ChineseInvestors.com Inc. (CIIX) Positioned for St
Post# of 346
(Total Views: 202)
Posted On: 03/07/2019 3:16:05 PM
ChineseInvestors.com Inc. (CIIX) Positioned for Strong 2019 Gains through CBD Biotech Co. Ltd. Subsidiary
- The hemp-CBD industry is estimated to reach $22 billion by 2020
- While still focusing on providing financial information and services, ChineseInvestors.com also aims to be a recognizable leader in the hemp-based CBD oil industry
- The company is considering a Nasdaq IPO for subsidiary CBD Biotech Co. Ltd. by late FY2019 or the following year
ChineseInvestors.com Inc. (OTCQB: CIIX), a leading financial information website for Chinese-speaking investors in the United States and Canada, is looking to gain momentum in its hemp-based CBD product and service division through a variety of avenues.
Aside from retail, online and direct sales of hemp-based products, the company has also historically offered customers a wide variety of products and services, including real-time market commentary, as well as analysis and education-related services in Chinese language character sets.
ChineseInvestors.com has cultivated a highly diversified revenue stream and has made inroads into the growing cannabis and CBD oil industry in several ways. The company developed a Chinese language application for the cannabis industry, and, in 2016, it launched a new website which could distribute industrial hemp-based CBD products.
ChineseInvestors.com aims to be a recognizable leader in the hemp-based CBD oil industry. In China, hemp-based CBD is legal as an additive to cosmetics, and this allows for a potential market of nearly two billion people desirous of quality CBD-infused products. As a standalone market distinct from cannabis itself, the hemp-CBD market is estimated to reach $22 billion by 2022, according to a study by the Brightfield Group (http://nnw.fm/BOX3q). As more of mainland China’s population sees the benefits of CBD oil products, the blossoming industry is poised for strong growth in that region.
Another aspect of ChineseInvestors.com’s growth strategy can be seen in the company’s acquisition of foreign enterprise CBD Biotech Co. Ltd. Referring to its pursuit of a national securities exchange listing for CBD Biotech, ChineseInvestors.com CEO and founder Warren Wang said in a news release (http://nnw.fm/u4rfF), “This is a part of a series of actions we have put into place to execute…our strategic plan to spin-out CBD Biotech.”
Wang continued, stating his belief that “listing on a national exchange speaks to the quality of CBD Biotech, will provide us with market visibility and access to capital, and further support our growth strategy.” He mentioned that the company hopes for a Nasdaq IPO of CBD Biotech late in FY2019 or early the following year (http://nnw.fm/7ed0C).
For more information, visit the company’s website at www.ChineseInvestors.com
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
- The hemp-CBD industry is estimated to reach $22 billion by 2020
- While still focusing on providing financial information and services, ChineseInvestors.com also aims to be a recognizable leader in the hemp-based CBD oil industry
- The company is considering a Nasdaq IPO for subsidiary CBD Biotech Co. Ltd. by late FY2019 or the following year
ChineseInvestors.com Inc. (OTCQB: CIIX), a leading financial information website for Chinese-speaking investors in the United States and Canada, is looking to gain momentum in its hemp-based CBD product and service division through a variety of avenues.
Aside from retail, online and direct sales of hemp-based products, the company has also historically offered customers a wide variety of products and services, including real-time market commentary, as well as analysis and education-related services in Chinese language character sets.
ChineseInvestors.com has cultivated a highly diversified revenue stream and has made inroads into the growing cannabis and CBD oil industry in several ways. The company developed a Chinese language application for the cannabis industry, and, in 2016, it launched a new website which could distribute industrial hemp-based CBD products.
ChineseInvestors.com aims to be a recognizable leader in the hemp-based CBD oil industry. In China, hemp-based CBD is legal as an additive to cosmetics, and this allows for a potential market of nearly two billion people desirous of quality CBD-infused products. As a standalone market distinct from cannabis itself, the hemp-CBD market is estimated to reach $22 billion by 2022, according to a study by the Brightfield Group (http://nnw.fm/BOX3q). As more of mainland China’s population sees the benefits of CBD oil products, the blossoming industry is poised for strong growth in that region.
Another aspect of ChineseInvestors.com’s growth strategy can be seen in the company’s acquisition of foreign enterprise CBD Biotech Co. Ltd. Referring to its pursuit of a national securities exchange listing for CBD Biotech, ChineseInvestors.com CEO and founder Warren Wang said in a news release (http://nnw.fm/u4rfF), “This is a part of a series of actions we have put into place to execute…our strategic plan to spin-out CBD Biotech.”
Wang continued, stating his belief that “listing on a national exchange speaks to the quality of CBD Biotech, will provide us with market visibility and access to capital, and further support our growth strategy.” He mentioned that the company hopes for a Nasdaq IPO of CBD Biotech late in FY2019 or early the following year (http://nnw.fm/7ed0C).
For more information, visit the company’s website at www.ChineseInvestors.com
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)